MX9602559A - Nuevos derivados de piperidina con actividad antagonista del paf. - Google Patents

Nuevos derivados de piperidina con actividad antagonista del paf.

Info

Publication number
MX9602559A
MX9602559A MX9602559A MX9602559A MX9602559A MX 9602559 A MX9602559 A MX 9602559A MX 9602559 A MX9602559 A MX 9602559A MX 9602559 A MX9602559 A MX 9602559A MX 9602559 A MX9602559 A MX 9602559A
Authority
MX
Mexico
Prior art keywords
antagonist activity
piperidine derivatives
paf antagonist
novel piperidine
paf
Prior art date
Application number
MX9602559A
Other languages
English (en)
Other versions
MXPA96002559A (es
Inventor
Elena Carceller
Pere J Jimenez
Nuria Recasens
Jordi Salas
Carmen Almansa
Javier Bartroli
Original Assignee
Uriach & Cia Sa J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach & Cia Sa J filed Critical Uriach & Cia Sa J
Publication of MX9602559A publication Critical patent/MX9602559A/es
Publication of MXPA96002559A publication Critical patent/MXPA96002559A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Los compuestos de formula general I y sus sales y solvatos son antagonistas de PAF y como tales son utiles en el tratamiento de diversas enfermedades o trastornos mediados por el PAF. Se describen también composiciones para su preparacion.
MXPA/A/1996/002559A 1994-11-07 1995-09-05 Nuevos derivados de piperidina con actividadantagonista del paf MXPA96002559A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES09402291A ES2087038B1 (es) 1994-11-07 1994-11-07 Nuevas piperidinas con actividad antagonista del paf.
ES9402291 1994-11-07
PCT/EP1995/003487 WO1996014317A1 (en) 1994-11-07 1995-09-05 Novel piperidine derivatives with paf antagonist activity

Publications (2)

Publication Number Publication Date
MX9602559A true MX9602559A (es) 1997-07-31
MXPA96002559A MXPA96002559A (es) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
PT738269E (pt) 2000-08-31
ES2147616T3 (es) 2000-09-16
DE69516503T2 (de) 2001-03-15
ATE192152T1 (de) 2000-05-15
DE69516503D1 (de) 2000-05-31
AU3563695A (en) 1996-05-31
NO962855L (no) 1996-07-05
NO962855D0 (no) 1996-07-05
GR3033528T3 (en) 2000-09-29
DK0738269T3 (da) 2000-08-28
JPH09507862A (ja) 1997-08-12
EP0738269A1 (en) 1996-10-23
DK0738269T5 (da) 2000-12-18
NO306345B1 (no) 1999-10-25
WO1996014317A1 (en) 1996-05-17
ES2087038A1 (es) 1996-07-01
EP0738269B1 (en) 2000-04-26
JP4018137B2 (ja) 2007-12-05
US5705504A (en) 1998-01-06
ES2087038B1 (es) 1997-03-16
KR100514201B1 (ko) 2005-12-29

Similar Documents

Publication Publication Date Title
ES2087038A1 (es) Nuevas piperidinas con actividad antagonista del paf.
NZ333801A (en) Piperidine and piperazine derivatives and their use as muscarinic antagonists
MY112102A (en) Therapeutic heterocycles.
PL308217A1 (en) Derivatives of 1-(oxo-acetyl)-piperidine-2-carboxylic as agents sensibilising multiple-drug-resistant cancer cells
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
IL114894A (en) Pyrrolidine derivatives as endothelin antagonists, pharmaceutical compositions containing them, and their use in the preparation of medicaments
IL117149A0 (en) Muscarinic antagonists
ATE427936T1 (de) Substituierte piperidin-verbindungen als modulatoren der chemokine receptor aktivitat
DE69715865D1 (de) Muscarin-antagonisten
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
EP0896533A4 (en) PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
MX9704777A (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen.
ATE201671T1 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
GB9502644D0 (en) Heterocyclic derivatives
GR3031215T3 (en) Bicyclic heterocycles as neurokinin a antagonists
HK1018265A1 (en) Piperazino derivatives as neurokinin antagonists
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.
GR3032950T3 (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
BG105923A (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
GB9116056D0 (en) Compounds
CA2180660A1 (en) Novel piperidine derivatives with paf antagonist activity
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: PALAU PHARMA, S.A.

MM Annulment or lapse due to non-payment of fees